XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
0.700
-0.028 (-3.86%)
At close: Mar 9, 2026, 4:00 PM EDT
0.702
+0.002 (0.28%)
After-hours: Mar 9, 2026, 4:00 PM EDT
XTL Biopharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 6 | 22 | 5 | 6 | 15 | 16 | |
| Market Cap Growth | -69.73% | 322.69% | -16.65% | -57.56% | -4.50% | 124.03% | |
| Enterprise Value | 6 | 21 | 3 | 2 | 12 | 12 | |
| Last Close Price | 0.73 | 2.03 | 1.01 | 1.21 | 2.77 | 3.03 | |
| PE Ratio | - | - | - | - | 34.41 | - | |
| PS Ratio | 6.65 | 49.63 | - | - | - | - | |
| PB Ratio | - | 4.12 | 2.38 | 1.59 | 2.81 | 4.34 | |
| P/TBV Ratio | - | - | 2.88 | 1.76 | 3.02 | 4.85 | |
| EV/Sales Ratio | 6.45 | 45.74 | - | - | - | - | |
| Debt / Equity Ratio | -1.83 | 0.03 | - | - | - | - | |
| Net Debt / Equity Ratio | 3.68 | -0.18 | -0.90 | -0.93 | -1.15 | -1.67 | |
| Net Debt / EBITDA Ratio | - | 0.51 | 2.63 | 4.23 | 5.95 | 6.38 | |
| Net Debt / FCF Ratio | - | 0.60 | 2.84 | 4.13 | 5.84 | 7.10 | |
| Asset Turnover | 0.62 | 0.08 | - | - | - | - | |
| Quick Ratio | 0.46 | 0.56 | 9.74 | 19.90 | 26.52 | 23.79 | |
| Current Ratio | 0.70 | 0.61 | 9.93 | 20.35 | 27.00 | 24.10 | |
| Return on Equity (ROE) | -577.13% | -26.83% | -57.31% | -28.89% | 9.73% | -58.34% | |
| Return on Assets (ROA) | -240.56% | -24.74% | -14.46% | -10.18% | -9.82% | -8.64% | |
| Return on Capital Employed (ROCE) | 12742.60% | -34.20% | -34.50% | -22.00% | -16.10% | -15.20% | |
| Earnings Yield | -98.06% | -4.59% | -33.65% | -21.22% | 2.91% | -18.84% | |
| FCF Yield | - | -7.47% | -13.35% | -14.18% | -7.01% | -5.43% | |
| Buyback Yield / Dilution | -54.39% | -29.23% | 0.00% | 11.48% | -19.71% | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.